Literature DB >> 11312946

Total syntheses of five indole alkaloids from the marine bryozoan Flustra foliacea.

M S Morales-Ríos1, O R Suárez-Castillo, J J Trujillo-Serrato, P Joseph-Nathan.   

Abstract

A general, efficient, and conceptually new approach to the total syntheses of marine-derived indole alkaloids, including (+/-)-flustramines A (1) and B (2), (+/-)-flustramides A (3) and B (4), and (+/-)-debromoflustramine B (5), is outlined. The key step in the syntheses involves the conjugated addition of an organomagnesium species derived from prenyl bromide to 2-hydroxyindolenines. Compounds 1, 2, and 5 have been synthesized in five steps with 23%, 17%, and 16% overall yield, respectively, whereas flustramides 3 and 4 have been synthesized in only four steps with 24% and 18% overall yield, respectively, on the basis of 2-hydroxyindolenines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11312946     DOI: 10.1021/jo0012647

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  4 in total

1.  Exploration of the interrupted Fischer indolization reaction.

Authors:  Alex W Schammel; Ben W Boal; Liansuo Zu; Tehetena Mesganaw; Neil K Garg
Journal:  Tetrahedron       Date:  2010-06-26       Impact factor: 2.457

2.  Exercising regiocontrol in palladium-catalyzed asymmetric prenylations and geranylation: unifying strategy toward flustramines A and B.

Authors:  Barry M Trost; Sushant Malhotra; Walter H Chan
Journal:  J Am Chem Soc       Date:  2011-04-26       Impact factor: 15.419

3.  Enantioselective organocatalytic construction of pyrroloindolines by a cascade addition-cyclization strategy: synthesis of (-)-flustramine B.

Authors:  Joel F Austin; Sung-Gon Kim; Christopher J Sinz; Wen-Jing Xiao; David W C MacMillan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

Review 4.  Indole alkaloid marine natural products: an established source of cancer drug leads with considerable promise for the control of parasitic, neurological and other diseases.

Authors:  Waseem Gul; Mark T Hamann
Journal:  Life Sci       Date:  2005-10-19       Impact factor: 5.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.